NewsRx

Search our medical news database

Heart Defects

Wellbutrin Linked To Serious Heart Problems For Newborns

Published in Women's Health Weekly, May 12th, 2011

2011 MAY 12 -- Wellbutrin (Bupropion HCI), which is manufactured by GlaxoSmithKline, was first approved by the FDA as an antidepressant in December 1985. A new study published in the American Journal of Obstetrics & Gynecology has suggested that women who use the antidepressant early on in the pregnancy have an increased risk of having a baby with a heart defect. Researchers found that more than 12,700 infants born from 1997 to 2004 in the United States whose mothers were taking Wellbutrin during the pregnancy, had more than double the risk of a heart defect known as left outflow defects.

Outflow Defect affects the blood-flow from the heart's left chambers...

Want to see the full article?

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now


Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Women's Health Weekly


NewsRx is Social

Follow us on your favorite social network by clicking on a button below:

Follow NewsRx on Twitter

NewsRx on Facebook

Awards

eHealthcare Leadership 2011 Winner
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

  • Google 2010 PageRank: #2 Among Top Health News and Media Publications
  • Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
  • Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
  • Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx on Facebook